Kyowa Kirin Co., Ltd. (4151)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Kyowa Kirin Co., Ltd. (4151)
Go deeper and ask any question about 4151
Company Performance
Current Price
as of Sep 17, 2024$23.24
P/E Ratio
17.99
Market Cap
$12.38B
Description
Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It handles the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. It also produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.
Metrics
Overview
- HQTokyo, TY
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- Ticker4151
- Price$23.237951+0.49%
Trading Information
- Market Cap$12.38B
- Float43.05%
- Average Daily Volume (1m)1,126,324
- Average Daily Volume (3m)1,095,969
- EPS$181.57
Company
- Revenue$476.00B
- Rev Growth (1yr)20.56%
- Net Income$23.14B
- Gross Margin71.06%
- EBITDA Margin24.33%
- EBITDA$31.00B
- EV$1.17T
- EV/Revenue2.46
- P/E17.99
- P/S3.65
Documents
Factset Street Account